Burlingame, CA, United States of America

Mark D Matteucci

USPTO Granted Patents = 65 

 

 

Average Co-Inventor Count = 2.7

ph-index = 30

Forward Citations = 8,654(Granted Patents)

Forward Citations (Not Self Cited) = 8,573(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • San Francisco, CA (US) (1990 - 1991)
  • Burkingue, CA (US) (2002)
  • Burlingame, CA (US) (1992 - 2005)
  • Portola Vall y, CA (US) (2005)
  • Portolla Valley, CA (US) (2006)
  • Redwood City, CA (US) (1990 - 2013)
  • Portola Valley, CA (US) (1999 - 2020)
  • Austin, TX (US) (2020)
  • South San Francisco, CA (US) (2019 - 2022)

Company Filing History:


Years Active: 1990-2022

Loading Chart...
Loading Chart...
Loading Chart...
65 patents (USPTO):

Title: Inventor Spotlight: Mark D Matteucci Revolutionizing Cancer Treatment

Introduction:

Mark D Matteucci, a prolific inventor based in Burlingame, CA, has made significant contributions to the field of oncology with a total of 65 patents under his name. His groundbreaking work in developing nitrobenzyl derivatives of anti-cancer agents has paved the way for innovative treatments in the fight against cancer.

Latest Patents:

Mark D Matteucci's latest patents focus on nitrobenzyl derivatives of anti-cancer agents. These compounds, as described in formula I, have shown promise in treating cancer by targeting specific pathways. The processes for their production and methods for administering these compounds represent a paradigm shift in cancer therapeutics.

Career Highlights:

During his career, Mark D Matteucci has worked with renowned companies such as Gilead Sciences, Inc., and Isis Pharmaceuticals, Inc. His tenure at these esteemed organizations has provided him with the platform to translate his innovative ideas into tangible solutions for cancer patients worldwide. His expertise and dedication have been instrumental in advancing the field of oncology.

Collaborations:

Mark D Matteucci has collaborated closely with notable peers in the industry, including Jian-Xin Duan and Kuei-Ying Lin. These collaborations have fostered a culture of innovation and knowledge-sharing, leading to the development of cutting-edge technologies aimed at improving cancer treatment outcomes.

Conclusion:

In conclusion, Mark D Matteucci stands out as a visionary inventor who has made remarkable contributions to cancer research through his inventive spirit and relentless pursuit of excellence. His patents, collaborations, and career highlights underscore his commitment to revolutionizing cancer treatment and bringing hope to patients battling this devastating disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…